Related Experiment Video
Updated: May 4, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Cardioembolic stroke: practical considerations for patient risk management and secondary prevention
Hardik Amin1, Richard J Nowak, Joseph L Schindler
1Department of Neurology, Yale University School of Medicine, New Haven, CT.
Insights
Cardioembolic stroke, often caused by atrial fibrillation, has high morbidity. This review covers diagnosis, management, and prevention strategies for cardioembolic stroke, including new anticoagulation therapies and managing reduced ejection fraction.
Area of Science:
- Neurology
- Cardiology
- Internal Medicine
Background:
- Cardioembolic (CE) stroke accounts for about 20% of ischemic strokes.
- Atrial fibrillation is the most frequent cause of CE stroke.
- CE strokes are linked to significant morbidity and early recurrence.
Purpose of the Study:
- To review the diagnosis and management of CE stroke from various cardiac origins.
- To highlight advances in primary and secondary prevention of CE stroke.
- To discuss emerging data on atrial fibrillation monitoring and new anticoagulation.
Main Methods:
- Literature review focusing on diagnosis and management of CE stroke.
- Synthesis of current understanding of cardiac mechanisms leading to CE stroke.
- Analysis of recent advancements in risk management and preventative therapies.
Main Results:
- Established atrial fibrillation as a primary CE stroke mechanism.
- Growing understanding of other cardiac sources: valvular disease, LV dysfunction, PFO.
- Identified key areas for improved primary and secondary prevention strategies.
Conclusions:
- Comprehensive management of CE stroke requires addressing diverse cardiac etiologies.
- Advances in anticoagulation and monitoring offer improved secondary prevention for atrial fibrillation patients.
- Further research into managing reduced ejection fraction is crucial for preventing CE stroke.
Abstract:
Cardioembolic (CE) stroke constitutes approximately 20% of all occurrence of ischemic stroke in patients. Atrial fibrillation remains the most common and most studied mechanism underlying CE stroke events. Cardioembolic strokes carry high morbidity and are associated with early recurrence in patients. Our understanding of other patient mechanisms associated with CE stroke, including valvular disease, left ventricular dysfunction, and patent foramen ovale, continues to grow. Our review summarizes the diagnosis and management of patients who have sustained CE stroke as a result of the aforementioned cardiac mechanisms. Advances in primary and secondary risk management for prevention of CE stroke are also highlighted in our article-specifically, emerging data regarding monitoring of patients with atrial fibrillation, new anticoagulation therapy, and management of patients with decreased ejection fraction.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Ischemic Stroke l: Introduction
Venous Thrombosis IV: Nursing Management
Atherosclerosis IV: Nursing Management

